Showing results (21-30 of 101) with videos related to
Sort By:
Pageof 11
Clinical Trials (London, England)|January 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trialsAnna Moseley, Michael LeBlanc, Boris Freidlin, et al.JAMA Network Open|December 1, 2020
Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical TrialsJoshua E Reuss, Diana Stern, Jared C Foster, et al.The Journal of Infectious Diseases|March 27, 2012
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndromeAlex Ray, Vickie Marshall, Thomas Uldrick, et al.Journal of the National Cancer Institute. Monographs|December 15, 2022
Integrating Geriatric Assessment Measures into National Cancer Institute Clinical TrialsAllison Magnuson, Noam Van der Walde, June M McKoy, et al.Critical Reviews in Immunology|January 17, 2008
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activityRobert Yarchoan, James M Pluda, Kathleen M Wyvill, et al.Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.Blood Cancer Journal|March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine eraRebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.Journal of the National Cancer Institute|January 2, 2017
T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for TreatmentCarla Casulo, Owen O'Connor, Andrei Shustov, et al.The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.Pageof 11